Search research articles
Contact Us
Filters
Showing results (1131-1140 of 1,231) with videos related to
Page
of 124
Sort By:
Applied Microbiology and Biotechnology
|
August 1, 1997
Safe biotechnology. 8. Transport of infectious and biological materials. Working Party "Safety in Biotechnology" of the European Federation of Biotechnology
H L Lelieveld, H Bachmayer, B Boon, et al.
Science Immunology
|
June 13, 2020
The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients
Lakshmanane Premkumar, Bruno Segovia-Chumbez, Ramesh Jadi, et al.
The Lancet. Global Health
|
July 25, 2025
The impact and cost-effectiveness of pulse oximetry and oxygen on acute lower respiratory infection outcomes in children in Malawi: a modelling study
Inês Li Lin, Eric D McCollum, Eric Buckley, et al.
Journal of Clinical Microbiology
|
October 17, 2020
COVID-19 Serology at Population Scale: SARS-CoV-2-Specific Antibody Responses in Saliva
Nora Pisanic, Pranay R Randad, Kate Kruczynski, et al.
Applied Microbiology and Biotechnology
|
July 1, 1996
Safe biotechnology. 7. Classification of microorganisms on the basis of hazard. Working Party "Safety in Biotechnology" of the European Federation Biotechnology
H L Lelieveld, B Boon, A Bennett, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 9, 2020
The RBD Of The Spike Protein Of SARS-Group Coronaviruses Is A Highly Specific Target Of SARS-CoV-2 Antibodies But Not Other Pathogenic Human and Animal Coronavirus Antibodies
Lakshmanane Premkumar, Bruno Segovia-Chumbez, Ramesh Jadi, et al.
The Journal of Allergy and Clinical Immunology
|
April 24, 2026
Dupilumab normalizes the eosinophilic esophagitis disease transcriptome
Wei Keat Lim, Matthew F Wipperman, Marc E Rothenberg, et al.
The American Journal of Gastroenterology
|
December 21, 2021
Development and Validation of Web-Based Tool to Predict Lamina Propria Fibrosis in Eosinophilic Esophagitis
Girish Hiremath, Lili Sun, Hernan Correa, et al.
Frontiers in Public Health
|
December 10, 2021
Application of SARS-CoV-2 Serology to Address Public Health Priorities
Amy C Sherman, Teresa Smith, Yerun Zhu, et al.
Cancer
|
October 18, 2018
The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapy
Mehmet A Bilen, Dylan J Martini, Yuan Liu, et al.
Page
of 124
Search research articles
Search
Showing results (1131-1140 of 1,231) with videos related to
Sort By:
Page
of 124
Applied Microbiology and Biotechnology
|
August 1, 1997
Safe biotechnology. 8. Transport of infectious and biological materials. Working Party "Safety in Biotechnology" of the European Federation of Biotechnology
H L Lelieveld, H Bachmayer, B Boon, et al.
Science Immunology
|
June 13, 2020
The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients
Lakshmanane Premkumar, Bruno Segovia-Chumbez, Ramesh Jadi, et al.
The Lancet. Global Health
|
July 25, 2025
The impact and cost-effectiveness of pulse oximetry and oxygen on acute lower respiratory infection outcomes in children in Malawi: a modelling study
Inês Li Lin, Eric D McCollum, Eric Buckley, et al.
Journal of Clinical Microbiology
|
October 17, 2020
COVID-19 Serology at Population Scale: SARS-CoV-2-Specific Antibody Responses in Saliva
Nora Pisanic, Pranay R Randad, Kate Kruczynski, et al.
Applied Microbiology and Biotechnology
|
July 1, 1996
Safe biotechnology. 7. Classification of microorganisms on the basis of hazard. Working Party "Safety in Biotechnology" of the European Federation Biotechnology
H L Lelieveld, B Boon, A Bennett, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 9, 2020
The RBD Of The Spike Protein Of SARS-Group Coronaviruses Is A Highly Specific Target Of SARS-CoV-2 Antibodies But Not Other Pathogenic Human and Animal Coronavirus Antibodies
Lakshmanane Premkumar, Bruno Segovia-Chumbez, Ramesh Jadi, et al.
The Journal of Allergy and Clinical Immunology
|
April 24, 2026
Dupilumab normalizes the eosinophilic esophagitis disease transcriptome
Wei Keat Lim, Matthew F Wipperman, Marc E Rothenberg, et al.
The American Journal of Gastroenterology
|
December 21, 2021
Development and Validation of Web-Based Tool to Predict Lamina Propria Fibrosis in Eosinophilic Esophagitis
Girish Hiremath, Lili Sun, Hernan Correa, et al.
Frontiers in Public Health
|
December 10, 2021
Application of SARS-CoV-2 Serology to Address Public Health Priorities
Amy C Sherman, Teresa Smith, Yerun Zhu, et al.
Cancer
|
October 18, 2018
The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapy
Mehmet A Bilen, Dylan J Martini, Yuan Liu, et al.
Page
of 124